全球骨科手術再生醫學產品市場：分析與預測 (2022-2028)

在 2021 年至 2027 年的預測期內，全球骨科再生醫學產品市場規模預計將以 4% 左右的複合年增長率增長。

外科產品的技術不斷進步和研發活動不斷增加，預計將擴大全球市場。 另一個因素是世界上越來越多的肥胖者。 此外，創傷修復、骨科疼痛管理、關節重建、軟骨和肌腱修復的增長以及關節炎和骨質疏鬆症等骨科問題發病率的上升預計將在未來幾年推動市場。

本報告研究了全球骨科再生醫學產品市場，並提供了市場概況、市場收入、按產品、應用、最終用戶和地區劃分的市場洞察力、市場動態、機會、公司概況等信息。

內容

第一章市場介紹

第 2 章調查方法和前提條件

• 整形外科再生醫學產品市場研究進程
• 整形外科再生醫學產品市場研究方法
• 受訪者簡介

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對全球骨科再生醫學產品市場的影響

第 6 章全球骨科再生醫學產品市場收入，2019-2027F

第 7 章市場洞察：按產品分類

• 同種異體移植
• 綜合
• 基於細胞
• 粘度補充劑

第 8 章市場洞察：按應用

• 整形手術中的疼痛管理
• 創傷修復
• 軟骨/肌腱修復
• 聯合重建
• 其他

第 9 章市場洞察：最終用戶

• 醫院
• 門診手術中心
• 其他

第 10 章市場洞察：按地區

• 北美市場
  • 美國
  • 加拿大
  • 其他北美地區
• 歐洲市場
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 其他歐洲
• 亞太市場
  • 中國
  • 日本
  • 印度
  • 澳大利亞
  • 亞太其他地區
• 其他區域市場

第 11 章骨科再生醫學市場：市場動態

• 市場驅動力
• 市場問題
• 影響分析

第十二章骨科再生醫學產品市場：機遇

第 13 章骨科再生醫學市場：趨勢

第 14 章法律和監管框架

第15章需求側與供給側分析

• 需求方分析
• 供應方分析

第 16 章價值鏈分析

第 17 章衝突場景

• 競爭格局
  • 波特的五力分析

第十八章公司簡介

• Anika Therapeutics, Inc.
• Vericel Corporation
• Baxter
• Zimmer Biomet
• Stryker
• Smith & Nephew
• AlloSource
• Amniox Medical, Inc.
• VSY Biotechnology
• Aptissen S.A.

第19章 免責事項

The orthopedic regenerative surgical products market is expected to register a CAGR of approx. 4% over the period of 2021-2027. Regenerative orthopedics help treat discomfort and pain in the musculoskeletal system and improve the healing of orthopedic conditions, such as ligaments, tendon injuries, muscles, bones, knee meniscus, intervertebral discs life, and cartilage. These parts of the body have a relatively low capacity for self-healing. Regenerative orthopedic surgical products help these tissues heal faster. Orthopedic regenerative surgical products can help some patients avoid orthopedic surgery altogether. The global orthopedic regenerative surgical products market is anticipated to witness an uptick with the growing technological advancement and increased research and development activities for the surgical product. Some other factors which drive the market include the rise in the obese population across the globe. In 2020, according to Trust For America's Health, the U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country's obesity crisis. Owing to these glaring statistics the demand for orthopedic regenerative surgical products is anticipated to grow in the forthcoming years because obesity causes an alteration of bone-regulating hormones, increased oxidative stress and inflammation, and altered bone cell metabolism which damages the bone internally. Furthermore, the increase in the number of trauma repair, orthopedic pain management, joint reconstruction, and cartilage and tendon repair as well as the rising incidences of orthopedic problems such as arthritis and osteoporosis, are expected to drive the market for orthopedic regenerative surgical products market in the coming years.

Some of the major factors such as obesity coupled with the growing healthcare expenditure are propelling the growth of this market in the region. Moreover, an increase in road accident cases also propels the growth of the market. For instance, according to the studies in 2020, One of the factors causing bone fractures is Road Traffic Accidents (RTAs), which are the first leading cause of death among people aged 15-29 years. In 2019, the global number of new cases of fracture was estimated to be 178 million (95%), an increase of 33*4% since 1990. Furthermore, the increasing prevalence of joint reconstruction, growing health care expenditure, and awareness among patients and healthcare are significantly growing the orthopedic regenerative surgical products market.

Anika Therapeutics, Inc., Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith & Nephew, AlloSource, Amniox Medical, Inc., VSY Biotechnology, Aptissen S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Product, the viscosupplements category accounted for the majority share in the market in 2020"

Based on product, the market is classified into allografts, synthetic, cell-based, and viscosupplements. Amongst these, the viscosupplement category accounted for a significant share of the market owing to the rising incidence of knee pain, osteoarthritis, and related symptoms and an increase in product availability driving the growth of this segment. Moreover, factors such as aging, obesity, excessive exercise, external injury, and genetic predisposition, further contribute to knee osteoarthritis, thus driving the market for orthopedic regenerative surgical products

"Among Applications, the joint reconstruction is expected to witness highest CAGR during the forecast period"

Based on application, the market is categorized into knee surgeries, hip surgeries, spine surgeries, and others. Among these, knee surgeries are expected to witness the highest CAGR during the forecast period. increasing surgical procedures, geriatric patients, and the incidence of trauma cases are likely to aid the segment's growth. In addition, increased adoption of regenerative solutions in joint reconstruction, and technological advancements also boost the segment of the market growth.

"Among End-Users, the Hospitals is expected to witness highest CAGR during the forecast period"

Based on end-users, the market is categorized into hospitals, ambulatory surgical centers, and others. Among these, the hospitals are expected to witness the highest CAGR during the forecast period. The hospital offers a wide range of treatment options in terms of pain management and orthopedic surgery. Furthermore, the factors contributing to the large share of the segment include a higher volume of orthopedic procedures performed in hospital settings.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the orthopedic regenerative surgical products market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the orthopedic regenerative surgical products market industry and generated revenue owing to the presence of well-established market players and technologically advanced healthcare facilities in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global orthopedic regenerative surgical products market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Orthopedic Regenerative Surgical Products Market
• 2.2. Research Methodology of the Orthopedic Regenerative Surgical Products Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET COVID-19 IMPACT

6 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Allografts
• 7.2. Synthetic
• 7.3. Cell-Based
• 7.4. Viscosupplements

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Orthopedic Pain Management
• 8.2. Trauma Repair
• 8.3. Cartilage and Tendon Repair
• 8.4. Joint Reconstruction
• 8.5. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Hospitals
• 9.2. Ambulatory Surgical Centers
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America Orthopedic Regenerative Surgical Products Market
  • 10.1.1. United States
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe Orthopedic Regenerative Surgical Products Market
  • 10.2.1. Germany
  • 10.2.2. France
  • 10.2.3. United Kingdom
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Orthopedic Regenerative Surgical Products Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia Pacific
• 10.4. Rest of World Orthopedic Regenerative Surgical Products Market Rest of Asia Pacific

11 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET DYNAMICS REST OF THE WORLD ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET OPPORTUNITIES

13 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Anika Therapeutics, Inc.
• 18.2. Vericel Corporation
• 18.3. Baxter
• 18.4. Zimmer Biomet
• 18.5. Stryker
• 18.6. Smith & Nephew
• 18.7. AlloSource
• 18.8. Amniox Medical, Inc.
• 18.9. VSY Biotechnology
• 18.10. Aptissen S.A.

19 DISCLAIMER